Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/18287
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Klevansky, Myron | - |
dc.contributor.author | John, Thomas | - |
dc.date.accessioned | 2018-08-30T04:08:01Z | - |
dc.date.available | 2018-08-30T04:08:01Z | - |
dc.date.issued | 2018-06 | - |
dc.identifier.citation | Journal of thoracic disease 2018; 10(Suppl 17): S1986-S1988 | - |
dc.identifier.issn | 2072-1439 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/18287 | - |
dc.language.iso | eng | - |
dc.title | Can molecularly targeted therapy cure patients with resected EGFR mutant NSCLC? | - |
dc.type | Journal Article | - |
dc.identifier.journaltitle | Journal of thoracic disease | - |
dc.identifier.affiliation | Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia | - |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia | - |
dc.identifier.doi | 10.21037/jtd.2018.04.156 | - |
dc.identifier.pubmedid | 30023098 | - |
dc.type.austin | Editorial | - |
dc.type.austin | Comment | - |
local.name.researcher | John, Thomas | |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
crisitem.author.dept | Medical Oncology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.